These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8356996)

  • 1. Continuing Developments with Nabumetone: An Investigators' Update. Proceedings of a symposium.
    Am J Med; 1993 Aug; 95(2A):1S-46S. PubMed ID: 8356996
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in Arthritis Therapy: Nabumetone Investigators' Meeting. Proceedings. Scottsdale, Arizona, September 27-28, 1991.
    J Rheumatol Suppl; 1992 Nov; 36():1-91. PubMed ID: 1474528
    [No Abstract]   [Full Text] [Related]  

  • 3. Nabumetone, a new nonsteroidal anti-inflammatory drug. Criteria for therapeutic selection. Proceedings of a symposium. San Diego, California, December 11 to 14, 1986.
    Am J Med; 1987 Oct; 83(4B):1-122. PubMed ID: 3687997
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and tolerability of nabumetone in the treatment of osteoarthritis of the knee joint: an open trial.
    Ben Dallah SK; Lenghi M
    J Int Med Res; 1994; 22(4):218-24. PubMed ID: 7958381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro.
    Skarydova L; Nobilis M; Wsól V
    Xenobiotica; 2013 Apr; 43(4):346-54. PubMed ID: 23020786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-steroidal anti-inflammatory drugs and renal response to exercise: a comparison of indomethacin and nabumetone.
    Olsen NV; Jensen NG; Hansen JM; Christensen NJ; Fogh-Andersen N; Kanstrup IL
    Clin Sci (Lond); 1999 Oct; 97(4):457-65. PubMed ID: 10491346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the transient intermediates generated from the photoexcitation of nabumetone: a comparison with naproxen.
    Martínez LJ; Scaiano JC
    Photochem Photobiol; 1998 Nov; 68(5):646-51. PubMed ID: 9825693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
    Friedel HA; Langtry HD; Buckley MM
    Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of nabumetone: a pilot in vitro study showing absence of injury to articular cartilage.
    Giordano N; Senesi M; Battisti E; Gonnelli S; Franci B; Campagna MS; Mattii G; Palumbo F; Gennari C
    Int J Tissue React; 1996; 18(4-6):105-8. PubMed ID: 9195245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe immediate reaction to nabumetone.
    Gonzalo-Garijo MA; Cordobés-Duran C; Lamilla-Yerga AM; Moreno-Gastón I
    J Investig Allergol Clin Immunol; 2007; 17(4):274-6. PubMed ID: 17694703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nabumetone: a new NSAID for rheumatoid arthritis and osteoarthritis.
    Roth SH
    Orthop Rev; 1992 Feb; 21(2):223-7. PubMed ID: 1538889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood and tissue fluid levels of a new non-steroidal anti-inflammatory preparation of nabumetone.
    Torre D; Sampietro C; Maggiolo F
    J Int Med Res; 1987; 15(6):368-73. PubMed ID: 3436484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nabumetone, a new non-steroidal anti-inflammatory drug, on urinary prostaglandin excretion in man.
    Giannessi D; Lazzerini G; Filipponi P; Mannarelli C; Vaiani G; Grossi E; De Caterina R
    Pharmacol Res; 1993; 28(3):229-41. PubMed ID: 8108313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of nabumetone induced pseudoporphyria.
    Checketts SR; Morgan GJ
    J Rheumatol; 1999 Dec; 26(12):2703-5. PubMed ID: 10606389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nabumetone--a new NSAID.
    Med Lett Drugs Ther; 1992 Apr; 34(868):38-40. PubMed ID: 1556995
    [No Abstract]   [Full Text] [Related]  

  • 16. The long-term U.S. study--a report on outcome and tolerance.
    Fleischmann R
    Eur J Rheumatol Inflamm; 1991; 11(3):50-3. PubMed ID: 1365481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GI bleeding associated with nabumetone.
    Voss GD; Schweitzer P
    Am J Hosp Pharm; 1994 Oct; 51(19):2506, 2508. PubMed ID: 7847412
    [No Abstract]   [Full Text] [Related]  

  • 18. Nabumetone compared with indomethacin in the treatment of osteoarthritis in general practice.
    Carle WK; Wade AG; Kill DC; Poland M
    J Rheumatol Suppl; 1992 Nov; 36():58-62. PubMed ID: 1474536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Absent enterohepatic circulation of the active metabolite of nabumetone].
    Brett MA; Greb WH; Kurth HJ; Rülander G; Haddock RE; Thawley AR
    Fortschr Med; 1988 Dec; 106(36):736. PubMed ID: 3069674
    [No Abstract]   [Full Text] [Related]  

  • 20. Nabumetone induced pseudoporphyria in childhood.
    Cron RQ; Finkel TH
    J Rheumatol; 2000 Jul; 27(7):1817-8. PubMed ID: 10914877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.